Literature DB >> 30406816

Should we combine vaginal prolapse surgery with continence surgery?

J Marinus van der Ploeg1, Jan-Paul W R Roovers2.   

Abstract

The risk of postoperative stress urinary incontinence (SUI) can be reduced by combining prolapse repair with continence surgery. However, more women face a serious adverse event (SAE) after vaginal prolapse surgery combined with a midurethral sling (MUS). It is difficult to predict a woman's individual postoperative SUI and SAE risk; therefore, weighing the benefits and risks of combination surgery is complex. We offer a concept that might help in considering combination surgery. According to this concept, women whose risk of needing subsequent surgery for postoperative SUI is on average 9% are likely to benefit from combination surgery.

Entities:  

Keywords:  Combination surgery; Current opinion; Midurethral sling; Pelvic organ prolapse; Stress urinary incontinence

Mesh：

Year:  2018        PMID： 30406816     DOI： 10.1007/s00192-018-3808-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


  9 in total

1.  Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations.

Authors:  Dionysios Mitropoulos; Walter Artibani; Markus Graefen; Mesut Remzi; Morgan Rouprêt; Michael Truss
Journal:  Eur Urol       Date:  2011-10-29       Impact factor: 20.096

2.  Prospective analysis of complications of tension-free vaginal tape from The Netherlands Tension-free Vaginal Tape study.

Authors:  Steven E Schraffordt Koops; Tanya M Bisseling; A Peter M Heintz; Harry A M Vervest
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

Review 3.  Mid-urethral sling operations for stress urinary incontinence in women.

Authors:  Abigail A Ford; Lynne Rogerson; June D Cody; Patricia Aluko; Joseph A Ogah
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

4.  Transvaginal prolapse repair with or without the addition of a midurethral sling in women with genital prolapse and stress urinary incontinence: a randomised trial.

Authors:  J M van der Ploeg; K Oude Rengerink; A van der Steen; J H S van Leeuwen; J Stekelenburg; M Y Bongers; M Weemhoff; B W Mol; C H van der Vaart; J-P W R Roovers
Journal:  BJOG       Date:  2015-03-09       Impact factor: 6.531

5.  A midurethral sling to reduce incontinence after vaginal prolapse repair.

Authors:  John T Wei; Ingrid Nygaard; Holly E Richter; Charles W Nager; Matthew D Barber; Kim Kenton; Cindy L Amundsen; Joseph Schaffer; Susan F Meikle; Cathie Spino
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

6.  Vaginal prolapse repair with or without a midurethral sling in women with genital prolapse and occult stress urinary incontinence: a randomized trial.

Authors:  J Marinus van der Ploeg; Katrien Oude Rengerink; Annemarie van der Steen; Jules H Schagen van Leeuwen; C Huub van der Vaart; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2016-01-06       Impact factor: 2.894

7.  Pelvic organ prolapse surgery with and without tension-free vaginal tape in women with occult or asymptomatic urodynamic stress incontinence: a randomised controlled trial.

Authors:  Lore Schierlitz; Peter L Dwyer; Anna Rosamilia; Alison De Souza; Christine Murray; Elizabeth Thomas; Richard Hiscock; Chahin Achtari
Journal:  Int Urogynecol J       Date:  2013-06-28       Impact factor: 2.894

8.  Major postoperative complications following surgical procedures for pelvic organ prolapse: a secondary database analysis of the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Elisabeth Erekson; Regan L Murchison; Kristen A Gerjevic; Vivienne T Meljen; Kris Strohbehn
Journal:  Am J Obstet Gynecol       Date:  2017-06-01       Impact factor: 8.661

9.  Prolapse surgery with or without incontinence procedure: a systematic review and meta-analysis.

Authors:  J M van der Ploeg; A van der Steen; S Zwolsman; C H van der Vaart; Jpwr Roovers
Journal:  BJOG       Date:  2017-11-13       Impact factor: 6.531
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.